市場調查報告書
商品編碼
1292431
按產品類型(傳統超聲、自動超聲)、按最終用途(醫院、診斷實驗室)分類的乳房超聲市場規模 - 全球預測至2032年Breast Ultrasound Market Size By Product Type (Conventional Ultrasound, Automated Ultrasound), By End-use (Hospitals, Diagnostics Laboratories) - Global Forecast to 2032 |
全球自動乳腺超聲系統(ABUS)的市場規模將在2032年之前呈指數式成長。美國對乳腺超聲和數位乳腺斷層掃描的有利報銷政策正在為行業成長鋪平道路。根據《平價醫療法案》,美國癌症協會癌症行動網路為乳腺癌篩查提供全面的保障。它還鼓勵各州通過州醫療補助計劃增加對低收入群體的醫療保障。
此外,乳房X光檢查在分析緻密乳腺組織方面的能力有限,這進一步增加了自動乳腺超聲系統的採用。 ABUS提供了更清晰、更詳細的圖像,加強了對癌性病變的可視化和特徵分析。這促使準確和及時的診斷,並通過檢測可能無法通過乳房X光檢查發現的癌症,幫助減少假陰性。
整個自動乳腺超聲系統市場根據產品、終端用途和地區進行細分。
基於產品,從2023年到2032年,自動乳腺容積掃描儀(ABVS)的市場佔有率將以超過15%的年復合成長率成長。最近ABVS的進步為細分市場的擴張提供了有利可圖的機會。一些ABVS系統現在結合了AR可視化技術,允許放射科醫生在虛擬環境中查看並與3D圖像互動。 AR技術提供了一個更直覺和身臨其境的體驗,增強了放射科醫生解釋圖像的能力,以獲得更好的病人結果。
基於終端用途,診斷成像中心部分的自動乳腺超聲系統市場價值將在2023-2032年積累豐厚的收益。印度和中國等發展中經濟體不斷成長的醫療支出增加了診斷成像中心的數量,為該領域的成長創造了明顯的推動力。此外,這些設施擁有高可用性的專業診斷工具,這使它們成為首選的醫療保健提供者。
這些中心還提供一系列的成像模式,允許採用多模式的方法檢測乳腺癌。結合多種成像技術,如乳房X光檢查、超音波和核磁共振,提高了檢測的準確性和敏感性,進一步推動了產品需求。
在區域方面,歐洲自動乳腺超聲系統市場到2032年將價值12億美元。由於越來越多的人採用久坐的生活方式和不適當的飲食習慣,乳腺癌的發病率不斷上升,增加了該地區的產品接受度。此外,該地區的行業參與者,如Koninklijke Philips NV和其他公司,正在投資於產品創新,以擴大他們的客戶群,因此,為區域ABUS行業創造了一個有利的成長前景。
Global Automated Breast Ultrasound Systems (ABUS) Market size will expand exponentially through 2032. Favorable reimbursement policies for breast ultrasound and digital breast tomosynthesis in the U.S. is paving the path for industry growth. Under the Affordable Care Act, the American Cancer Society Cancer Action Network offers comprehensive coverage for breast cancer screening. It also encourages states to increase their healthcare coverage for people from low-income groups through the state Medicaid programs.
Moreover, the limited capability of mammography in analyzing dense breast tissues has further increased the adoption of automated breast ultrasound systems. ABUS provides clearer and more detailed images, enhancing the visualization and characterization of cancerous lesions. This results in accurate and timely diagnosis and helps reduce false negatives by detecting cancers that may not have detected through mammography.
The overall automated breast ultrasound systems market is segmented based on product, end-use, and region.
Based on the product, the automated breast volume scanner (ABVS) market share will grow at more than 15% CAGR from 2023 to 2032. Recent advancements in ABVS are presenting lucrative opportunities for segment expansion. Some ABVS systems now incorporate AR visualization technology, allowing radiologists to view and interact with the 3D images in a virtual environment. AR technology provides a more intuitive and immersive experience, enhancing the radiologist's ability to interpret the images for better patient outcomes.
Based on end-use, automated breast ultrasound systems market value from the diagnostic imaging centers segment will amass lucrative gains over 2023-2032. Growing healthcare expenditure in developing economies such as India and China has increased the number of diagnostic imaging centers, creating a notable impetus for segment growth. Moreover, these facilities have high availability of specialized diagnostic tools, which has made them a preferred healthcare provider.
These centers also offer a range of imaging modalities, allowing for a multi-modal approach to breast cancer detection. Combining multiple imaging techniques, such as mammography, ultrasound, and MRI, enhances the accuracy and sensitivity of detection, further driving product demand.
On the regional front, Europe automated breast ultrasound systems market will be worth USD 1.2 billion by 2032. Rising prevalence of breast cancer attributed to the growing adoption of a sedentary lifestyle and inadequate eating habits has increased product uptake in the region. Moreover, industry players in the region, such as Koninklijke Philips N.V. and others, are investing in product innovations to broaden their customer base, thus, creating a favorable growth outlook for the regional ABUS industry.